Deal date

KANDO id: 1050202

Financial Transaction:

Series D


Neurelis Inc


Currency
United States Dollar
Value in original currency
114,000,000
Value in USD
114,000,000

Note
Funding to support the commercialization of the company's lead orphan drug product, VALTOCO® (diazepam nasal spray), and to continue the development and expansion of the company's neuroscience pipeline.